Johnson & Johnson's global head of R&D talks about booster

Dr. Mathai Mammen talks about J&J's new data showing that giving a booster shot of its COVID vaccine two months after the first dose results in higher efficacy and an increased antibody response.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting